Table 2.

Competing risk analysis for waitlist mortality among all patients listed for liver transplant

	Univariable			Multivariable*
	SHR	95% CI	P value	SHR	95% CI	P value
Age ≥65 (at listing)	1.43	1.36–1.50	<0.001	1.51	1.40 – 1.64	<0.001
HCC	0.83	0.66–1.05	0.12	0.87	0.55 – 1.37	0.55
Female gender	1.19	1.10–1.28	<0.001
Liver diagnosis
Alcohol	Ref			Ref
Hepatitis C	1.09	0.95–1.24	0.22	1.16	1.11 – 1.23	<0.001
NASH	1.15	1.02–1.31	0.03	1.08	1.03 – 1.14	0.002
Autoimmune/cholestatic	0.97	0.86–1.09	0.62	0.93	0.85 – 1.02	0.12
Other	1.11	0.90–1.36	0.33	1.08	0.94 – 1.24	0.30
MELD at transplant per point	1.05	1.02–1.08	<0.001	1.04	1.01–1.07	0.01
Hepatic encephalopathy	2.84	2.09–3.87	<0.001	1.75	1.55–1.97	<0.001
Private insurance	0.76	0.71–0.81	<0.001	0.86	0.79–0.93	<0.001

SHR, subhazard ratio; CI, confidence interval; HCC, hepatocellular carcinoma; NASH, nonalcoholic steatohepatitis; MELD, model for end stage liver disease

^*Multivariable model also adjusted for blood type, region, era, and interaction term between age and HCC